456
Views
4
CrossRef citations to date
0
Altmetric
Original article

The SimpleMix study with biphasic insulin aspart 30: a randomized controlled trial investigating patient-driven titration versus investigator-driven titration

, , , &
Pages 2483-2492 | Accepted 28 Aug 2014, Published online: 29 Sep 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (3)

Wenying Yang, Canan Ersoy, Guixia Wang, Shandong Ye, Jun Liu, Heng Miao, Arthur Asirvatham, Shanti Werther, Priti Kadu & Francis Chow. (2019) Efficacy and safety of three-times-daily versus twice-daily biphasic insulin aspart 30 in patients with type 2 diabetes mellitus inadequately controlled with basal insulin combined with oral antidiabetic drugs. Diabetes Research and Clinical Practice 150, pages 158-166.
Crossref
Andreas Liebl, Viswanathan Mohan, Wenying Yang, Krzysztof Strojek & Sultan Linjawi. (2018) 15 Years of Experience with Biphasic Insulin Aspart 30 in Type 2 Diabetes. Drugs in R&D 18:1, pages 27-39.
Crossref
Abdelmjid Chraibi, Shoorook Al-Herz, Bich Dao Nguyen, Djoko W. Soeatmadji, Anil Shinde, Balasubramanian Lakshmivenkataraman & Samir H. Assaad-Khalil. (2017) An RCT Investigating Patient-Driven Versus Physician-Driven Titration of BIAsp 30 in Patients with Type 2 Diabetes Uncontrolled Using NPH Insulin. Diabetes Therapy 8:4, pages 767-780.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.